Código QR (código de barras bidimensional)

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients

Abstract Background Specific clinical risk factors may contribute to improving or worsening neurological functions in acute ischemic stroke (AIS) patients pre-treated with a combined cholesterol reducer and recombinant tissue plasminogen activator (rtPA) therapy. In this study, clinical risk factors...

ver descrição completa

Na minha lista:
Principais autores: Nicolas Poupore, Dan Strat, Tristan Mackey, Katherine Brown, Ashley Snell, Thomas I. Nathaniel
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-05-01
coleção:Lipids in Health and Disease
Assuntos:
Cholesterol reducer
NIHSS score
Neurological deficits
Thrombolytic therapy
Ischemic stroke
Acesso em linha:http://link.springer.com/article/10.1186/s12944-020-01270-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados